# A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants

> **NCT04465396** · PHASE1 · COMPLETED · sponsor: **Shire** · enrollment: 64 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Teduglutide
- **DEVICE:** Syringe Injection
- **DEVICE:** Pen injector

## Key facts

- **NCT ID:** NCT04465396
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-13
- **Primary completion:** 2021-08-20
- **Final completion:** 2021-08-20
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2022-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04465396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04465396, "A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04465396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*